Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease

Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease

Background: In patients with chronic kidney disease (CKD), trimethylamine n-oxide (TMAO) accumulation exacerbates inflammation and contributes to oxidative stress. These complications are putatively linked to the development of cardiovascular diseases. Despite the known associations, the variation i...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcia Ribeiro, Julie Ann Kemp, Ludmila Cardozo, Drielly Vargas, Marcelo Ribeiro-Alves, Peter Stenvinkel, Denise Mafra
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Toxins
Subjects:
chronic kidney disease
uremic toxins
dialysis
trimethylamine N-oxide
Online Access:https://www.mdpi.com/2072-6651/17/1/15
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items